Clovis Oncology to Present at the 35th Annual J.P. Morgan Healthcare Conference
10 January 2017 - 12:00AM
Business Wire
Clovis Oncology, Inc. (Nasdaq: CLVS) today announced that its
Chief Executive Officer and President, Patrick J. Mahaffy, will
present at the 35th Annual J.P. Morgan Healthcare Conference on
Tuesday, January 10, 2017 at 2:30 PM Pacific Time. The conference
will be held at the Westin St. Francis Hotel in San Francisco.
A live webcast of the presentation and breakout session can be
accessed through the investor relations section of the Company’s
website at www.clovisoncology.com. Following the live presentation,
a replay of the webcast will be available on the Company’s website
for 30 days.
About Clovis Oncology
Clovis Oncology, Inc. is a biopharmaceutical company focused on
acquiring, developing and commercializing innovative anti-cancer
agents in the U.S., Europe and additional international markets.
Clovis Oncology targets development programs at specific subsets of
cancer populations, and simultaneously develops diagnostic tools
that direct a compound in development to the population that is
most likely to benefit from its use. Clovis Oncology is
headquartered in Boulder, Colorado, and has additional offices in
San Francisco, California and Cambridge, UK.
View source
version on businesswire.com: http://www.businesswire.com/news/home/20170109005277/en/
Clovis Oncology, Inc.Anna Sussman,
303-625-5022asussman@clovisoncology.comorBreanna Burkart,
303-625-5023bburkart@clovisoncology.com
Clovis Oncology (NASDAQ:CLVS)
Historical Stock Chart
From Apr 2024 to May 2024
Clovis Oncology (NASDAQ:CLVS)
Historical Stock Chart
From May 2023 to May 2024
Real-Time news about Clovis Oncology Inc (NASDAQ): 0 recent articles
More Clovis Oncology, Inc. (MM) News Articles